Status:
TERMINATED
CNAP vs IABP in Pregnant Women With Placenta Accreta
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Placenta Accreta
Blood Pressure
Eligibility:
FEMALE
18-40 years
Brief Summary
The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the inves...
Detailed Description
Study Overview This is a prospective, observational study. Study Procedures Patients who meet inclusion criteria with no exclusions will be approached to provide written informed consent. Enrolled p...
Eligibility Criteria
Inclusion
- Women aged 18-40 years old with pregnancy complicated by accreta spectrum undergoing elective, scheduled cesarean delivery and possible hysterectomy
Exclusion
- Women aged \<18
- Patients with cardiac arrhythmia
- Vascular pathologies of the upper limbs (recent vascular surgery, Reynaud's disease, vascular stenosis)
- Contraindication to neuraxial anesthesia
- Emergent cases
- Droplet or airborne precautions (as determined by BIDMC infection control policy)
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04671680
Start Date
January 15 2021
End Date
June 1 2025
Last Update
October 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215